Brazil: How has the Madrid Protocol been implemented and what next?

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Brazil: How has the Madrid Protocol been implemented and what next?

Sponsored by

daniel-400px.png
握手をするビジネスウーマンとビジネスマン、締結、成約、契約

On October 2 2019, Brazil joined the Madrid protocol. The success of this can be proven by numbers.

Until March 5 2020, 3,126 marks were designated to Brazil. The United States, the European market, China, Great Britain and Germany were the top filer countries. Thus far, most applications have come from well-established companies with worldwide reach, such as GSK, BMW, Syngenta Group, Apple, Luis Vuitton, Roche and others.

These numbers are expected to rise when the Protocol is fully implemented but, unfortunately, there are still important procedures pending including the multiclass system, co-ownership and division of applications/registrations. These procedures were scheduled to come into effect on March 9 2020 but were postponed indefinitely by the BPTO.

Another important point is the publication of international designations in the BPTO Official Bulletin.

In accordance with Brazilian law, all designations need to be locally published opening a 60 day term for the filing of oppositions, which are also published, opening another 60 days term for the filing of counterarguments. Up until now no publication has yet taken place which means that (1) applications filed within the protocol are likely to take much longer to be analysed than locally filed applications and (2) it is too early to anticipate the problems that these applications will encounter and how they will be analysed by the BPTO.

Furthermore, there is a catch concerning oppositions as they will only be published locally and will not be displayed on the WIPO portal which means that it is wise to have a local agent monitoring Brazilian designations.

Hiccups aside, once these problems are solved the Protocol will undoubtedly be an important tool to be used by companies to protect their trademark rights in Brazil.

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article